The slow startup and suboptimal efficiency of microbial carbon sequestration and methane-production systems have not been fully resolved despite their contribution to sustainable energy production and the reduction of greenhouse gas emissions. These systems often grapple with persistent hurdles, including interference from miscellaneous bacteria and the slow enrichment of methanogens. To address these issues, this paper examines the synergistic effect of coupling β-lactam antibiotics with an electrolytic cell on the methanogenic process. The results indicated that β-lactam antibiotics exhibited inhibitory effects on Campylobacteria and Alphaproteobacteria (two types of miscellaneous bacteria), reducing their relative abundance by 53.03% and 87.78%, respectively. Nevertheless, it also resulted in a decrease in hydrogenogens and hindered the CO2 reduction pathway. When coupled with an electrolytic cell, sufficient electrons were supplied for CO2 reduction to compensate for the hydrogen deficiency, effectively mitigating the side effects of antibiotics. Consequently, a substantial improvement in methane production was observed, reaching 0.57 mL·L-1·d-1, exemplifying a remarkable 6.3-fold increase over the control group. This discovery reinforces the efficiency of methanogen enrichment and enhances methane-production levels.
Keywords: PICRUSt2; inhibiting miscellaneous bacteria; microbial community; microbial methanogenic system; rapid start technology.